BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Chronic hepatitis B
1
From virological selection to immune stratification: Hepatitis B virus-specific T cells for precision pegylated interferon therapy in chronic hepatitis B
9/17/2026 5:48:20 AM | Browse: 7 | Download: 19
2
Biological interpretation of baseline hepatitis B surface antigen and cirrhosis in determining interferon treatment duration
9/7/2026 2:26:33 AM | Browse: 21 | Download: 39
3
Predictive model to identify patients requiring extended interferon therapy in chronic hepatitis B
9/1/2026 6:22:40 AM | Browse: 17 | Download: 8
4
Routine laboratory model for identifying significant fibrosis in chronic hepatitis B
6/26/2026 9:50:21 AM | Browse: 39 | Download: 145
5
Comparing validated hepatocellular carcinoma risk scores for chronic hepatitis B against current Australian surveillance guidelines
6/26/2026 9:50:19 AM | Browse: 27 | Download: 118
6
Letter to the Editor: Physical functioning as a neglected determinant of antiviral adherence in chronic hepatitis B
6/18/2026 7:52:55 AM | Browse: 45 | Download: 164
7
Bone and renal safety of initial antiviral therapy using tenofovir alafenamide fumarate or entecavir for chronic hepatitis B
5/29/2026 7:26:46 AM | Browse: 42 | Download: 233
8
Beyond fibrosis: The imperative for dual steatosis and fibrosis assessment in chronic hepatitis B and metabolic dysfunction-associated steatotic liver disease co-pathology
5/26/2026 3:52:09 AM | Browse: 29 | Download: 114
9
Diagnostic efficacy and influencing factors of non-invasive liver fibrosis scores in chronic hepatitis B fibrosis: Cross-sectional study
5/26/2026 3:52:08 AM | Browse: 48 | Download: 170
10
Why does hepatitis B remain underprioritized? A view through lived experience
4/23/2026 11:05:50 AM | Browse: 81 | Download: 295
11
Baseline hepatitis B surface antigen and cirrhosis predict extended interferon therapy in chronic hepatitis B: A retrospective study
3/19/2026 7:07:29 AM | Browse: 73 | Download: 344
12
Predictive tool for evident histological liver injury in chronic hepatitis B patients: Development and validation
2/12/2026 11:20:21 AM | Browse: 127 | Download: 566
13
Effects of tenofovir amibufenamide and entecavir on estimated glomerular filtration rate in treatment-naïve patients with chronic hepatitis B
2/12/2026 11:20:19 AM | Browse: 127 | Download: 535
14
Adherence to antiviral treatment among people living with chronic hepatitis B: A global survey
12/25/2025 9:13:55 AM | Browse: 107 | Download: 464
15
Retreatment hepatitis B surface antigen clearance prediction model identifies pegylated interferon alpha candidates in chronic hepatitis B
11/28/2025 3:10:38 AM | Browse: 282 | Download: 601
16
Meta-analysis of factors associated with the incidence of comorbid depression and anxiety in patients with chronic hepatitis B
11/4/2025 2:41:47 AM | Browse: 289 | Download: 683
17
Gray zone and the need for expansion in chronic hepatitis B: From theory to clinical practice
10/27/2025 10:57:50 AM | Browse: 408 | Download: 575
18
Association of serum hepatitis B surface antigen with hepatitis B virus DNA and hepatic function in patients with chronic hepatitis B
10/24/2025 7:36:34 AM | Browse: 343 | Download: 521
19
Association between hepatitis B virus markers and liver fibrosis staging in patients with chronic hepatitis B
10/24/2025 7:36:26 AM | Browse: 210 | Download: 441
20
Psychological distress and treatment adherence-challenges of patients with chronic hepatitis B: Risk factors and integrated nursing strategies
9/26/2025 8:18:47 AM | Browse: 549 | Download: 555
21
Functional cure in an occult hepatitis B virus infection patient on sequential therapy: A case report
9/25/2025 11:24:05 AM | Browse: 178 | Download: 543
22
Anti-hepatitis B virus effects of traditional Chinese medicine: Learning from clinical trials in the past twenty years
9/25/2025 11:24:00 AM | Browse: 399 | Download: 502
23
Chronic hepatitis B: Is it time for expanded antiviral treatment?
9/25/2025 9:22:03 AM | Browse: 263 | Download: 373
24
Advancing therapeutic vaccines for chronic hepatitis B: Integrating reverse vaccinology and immunoinformatics
7/25/2025 12:09:41 PM | Browse: 290 | Download: 671
25
Chronic hepatitis B with type 2 diabetes mellitus: Association between glycemic control and liver fibrosis
7/15/2025 8:26:32 AM | Browse: 292 | Download: 985
26
Rate of abnormal renal function index and related risk factors in patients with chronic hepatitis B
7/4/2025 9:23:52 AM | Browse: 209 | Download: 946
27
Assessing the role of Mac-2 binding protein glycosylation isomer in the management of patients with chronic hepatitis B
5/27/2025 7:04:48 AM | Browse: 352 | Download: 1072
28
Microbial characteristics of gut microbiome dysbiosis in patients with chronic liver disease
5/27/2025 7:04:47 AM | Browse: 312 | Download: 915
29
Attenuation imaging: Diagnostic differences in hepatic steatosis for chronic hepatitis B vs metabolic dysfunction-associated steatotic liver disease patients
3/13/2025 10:11:05 AM | Browse: 275 | Download: 892
30
Tenofovir amibufenamide: A potential alternative for chronic hepatitis B treatment
2/26/2025 4:21:35 AM | Browse: 258 | Download: 656
31
CXCR5+CD8+ T cells as immune regulators in HBeAg-positive chronic hepatitis B under interferon-alpha treatment
12/20/2024 3:53:46 AM | Browse: 103 | Download: 522
32
Current status of drug therapy for chronic hepatitis B
12/18/2024 7:36:02 AM | Browse: 310 | Download: 869
33
Revolutionizing the understanding of liver disease: Metabolism, function and future
11/29/2024 2:50:19 PM | Browse: 370 | Download: 1058
34
Influence of nonalcoholic fatty liver disease on the therapeutic effect of nucleoside (acid) analogs for hepatitis B virus
11/29/2024 2:50:18 PM | Browse: 364 | Download: 1298
35
Recurrence and influencing factors of hepatitis B surface antigen seroclearance induced by peginterferon alpha-based regimens
11/12/2024 6:08:07 AM | Browse: 181 | Download: 1180
36
Elimination of hepatitis B as a public health threat: Addressing the challenge and taking action
11/6/2024 9:50:59 AM | Browse: 291 | Download: 1007
37
Portocaval shunts' role in gut microbiota and hepatic encephalopathy: The gut-to-brain pathway
10/31/2024 10:42:49 AM | Browse: 346 | Download: 923
38
Chronic hepatitis B: Prevent, diagnose, and treat before the point of no return
10/21/2024 7:03:25 AM | Browse: 336 | Download: 824
39
Liver stiffness in hepatocellular carcinoma and chronic hepatitis patients: Hepatitis B virus infection and transaminases should be considered
7/26/2024 10:33:30 AM | Browse: 361 | Download: 1119
40
Chronic hepatitis B virus infection in Eastern Ethiopia: Clinical characteristics and determinants of cirrhosis
7/26/2024 10:33:30 AM | Browse: 430 | Download: 1589
41
Effectiveness and safety of tenofovir amibufenamide in chronic hepatitis B patients
7/9/2024 2:00:35 PM | Browse: 291 | Download: 787
42
Risk of hepatitis B virus reactivation in cancer patients undergoing treatment with tyrosine kinase-inhibitors
6/25/2024 10:41:21 AM | Browse: 393 | Download: 818
43
Hepatitis B cure: Current situation and prospects
6/20/2024 3:42:22 AM | Browse: 361 | Download: 1021
44
Liver histological changes in untreated chronic hepatitis B patients in indeterminate phase
6/20/2024 3:42:22 AM | Browse: 228 | Download: 1359
45
Prediction model for hepatitis B e antigen seroconversion in chronic hepatitis B with peginterferon-alfa treated based on a response-guided therapy strategy
3/27/2024 1:28:19 PM | Browse: 393 | Download: 1465
46
Chronic hepatitis B and occult infection in chemotherapy patients - evaluation in oncology and hemato-oncology settings: The CHOICE study
3/11/2024 2:44:49 PM | Browse: 499 | Download: 1488
47
Risk of hepatitis B virus reactivation in oncological patients treated with tyrosine kinase inhibitors: A case report and literature analysis
3/6/2024 6:10:52 AM | Browse: 476 | Download: 1331
48
Effect of viral hepatitis on type 2 diabetes: A Mendelian randomization study
2/4/2024 10:57:42 AM | Browse: 545 | Download: 1806
49
Antiviral treatment standards for hepatitis B: An urgent need for expansion
1/26/2024 7:56:29 AM | Browse: 588 | Download: 1387
50
Efficacy and safety of tenofovir alafenamide in patients with chronic hepatitis B exhibiting suboptimal response to entecavir
12/6/2023 8:08:49 AM | Browse: 555 | Download: 1625